Research Highlight | Published:


Teplizumab delays onset of type 1 diabetes mellitus

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original article

    1. Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. (2019)

    Download references

    Author information

    Correspondence to Alan Morris.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark